Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 23 August 1985:
Vol. 229. no. 4715, pp. 759 - 762
DOI: 10.1126/science.2992084

Articles

Science, Vol 229, Issue 4715, 759-762
Copyright © 1985 by American Association for the Advancement of Science


articles

Genomic diversity of human T-lymphotropic virus type III (HTLV-III)

F Wong-Staal, GM Shaw, BH Hahn, SZ Salahuddin, M Popovic, P Markham, R Redfield, and RC Gallo

The DNA genomes of human T-lymphotropic virus type III (HTLV-III) isolated from 18 individuals with AIDS or who were at risk for AIDS were evaluated for evidence of variation. Although all of the 18 viral DNA's hybridized throughout their entire genomes to a full-length cloned probe of the original HTLV-III isolate, each of the 18 isolates showed a different restriction enzyme pattern. The number of restriction site differences between isolates ranged from only 1 site in 23 to at least 16 sites in 31. No particular viral genotype was associated with a particular disease state and 2 of the 18 patients had evidence of concurrent infection by more than one viral genotype. Propagation of three different viral isolates in vitro for up to 9 months did not lead to detectable changes in their restriction patterns. These findings indicate that different isolates of HTLV-III comprise a spectrum of highly related but distinguishable viruses and have important implications regarding the pathogenicity of HTLV-III and attempts to develop effective diagnostic, therapeutic, and preventive measures for this virus.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Spread of distinct human immunodeficiency virus type 1 AG recombinant lineages in Africa.
M. Cornelissen, R. van den Burg, F. Zorgdrager, and J. Goudsmit (2000)
J. Gen. Virol. 81, 515-523
   Abstract »    Full Text »
Complement-Mediated Anti-HIV-1 Effect Induced by Human IgM Monoclonal Antibody Against Ganglioside GM2.
X. Wu, N. Okada, H. Momota, R. F. Irie, and H. Okada (1999)
J. Immunol. 162, 533-539
   Abstract »    Full Text »    PDF »
Biological Agents in Infectious Diseases.
S. G. Louie and G. S. Jaresko (1991)
Journal of Pharmacy Practice 4, 326-341
   Abstract »    PDF »
Induction of CD4+ human cytolytic T cells specific for HIV-infected cells by a gp160 subunit vaccine.
R. Orentas, J. Hildreth, E Obah, M Polydefkis, G. Smith, M. Clements, and R. Siliciano (1990)
Science 248, 1234-1237
   Abstract »    PDF »
The Acquired Immunodeficiency Syndrome (AIDS) Dementia Complex.
D. D. Ho, D. E. Bredesen, H. V. Vinters, and E. S. Daar (1989)
Ann Intern Med 111, 400-410
   Abstract »    PDF »
Risk of Developing AIDS in HIV-Infected Cohorts of Hemophilic and Homosexual Men.
J. Jason, K.-J. Lui, M. V. Ragni, N. A. Hessol, and W. W. Darrow (1989)
JAMA 261, 725-727
   Abstract »    PDF »
Biologic features of HIV-1 that correlate with virulence in the host.
C Cheng-Mayer, D Seto, M Tateno, and J. Levy (1988)
Science 240, 80-82
   Abstract »    PDF »
AIDS: an international perspective.
P Piot, F. Plummer, F. Mhalu, J. Lamboray, J Chin, and J. Mann (1988)
Science 239, 573-579
   Abstract »    PDF »
The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.
R. Price, B Brew, J Sidtis, M Rosenblum, A. Scheck, and P Cleary (1988)
Science 239, 586-592
   Abstract »    PDF »
Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1.
M Kowalski, J Potz, L Basiripour, T Dorfman, W. Goh, E Terwilliger, A Dayton, C Rosen, W Haseltine, and J Sodroski (1987)
Science 237, 1351-1355
   Abstract »    PDF »
Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.
Y Koyanagi, S Miles, R. Mitsuyasu, J. Merrill, H. Vinters, and I. Chen (1987)
Science 236, 819-822
   Abstract »    PDF »
AIDS in Africa: an epidemiologic paradigm.
T. Quinn, J. Mann, J. Curran, and P Piot (1986)
Science 234, 955-963
   Abstract »    PDF »
Transfusion-Acquired Human Immunodeficiency Virus Infection Among Immunocompromised Persons.
K. C. ANDERSON, B. C. GORGONE, R. G. MARLINK, R. FERRIANI, M. E. ESSEX, P. M. BENZ, and J. E. GROOPMAN (1986)
Ann Intern Med 105, 519-527
   Abstract »    PDF »
Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS.
B. Hahn, G. Shaw, M. Taylor, R. Redfield, P. Markham, S. Salahuddin, F Wong-Staal, R. Gallo, E. Parks, and W. Parks (1986)
Science 232, 1548-1553
   Abstract »    PDF »
Human T-Cell Lymphotropic Virus Type III Infection in a Cohort of Homosexual Men in New York City.
C. E. Stevens, P. E. Taylor, E. A. Zang, J. M. Morrison, E. J. Harley, S. R. de Cordoba, C. Bacino, R. C. Y. Ting, A. J. Bodner, M. G. Sarngadharan, et al. (1986)
JAMA 255, 2167-2172
   Abstract »    PDF »
Binding of HTLV-III/LAV to T4+ T cells by a complex of the 110K viral protein and the T4 molecule.
J. McDougal, M. Kennedy, J. Sligh, S. Cort, A Mawle, and J. Nicholson (1986)
Science 231, 382-385
   Abstract »    PDF »
AIDS, Social Sciences, and Health Education: A Personal Perspective.
J. E. Osborn (1986)
Health Educ Behav 13, 287-299
   PDF »
Genomic heterogeneity of AIDS retroviral isolates from North America and Zaire.
S Benn, R Rutledge, T Folks, J Gold, L Baker, J McCormick, P Feorino, P Piot, T Quinn, and M Martin (1985)
Science 230, 949-951
   Abstract »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)